Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	humoral immune response mediated by circulating immunoglobulin	NOD2 EXO1 C4A C4B C6 C7 C8B	1.51e-06	62	188	7	GO:0002455
GeneOntologyBiologicalProcess	regulation of post-transcriptional gene silencing	ZMPSTE24 PUM2 DND1 FOCAD PUM1	2.05e-05	37	188	5	GO:0060147
GeneOntologyBiologicalProcess	response to DNA damage checkpoint signaling	ZMPSTE24 MUS81 FBH1	4.04e-05	8	188	3	GO:0072423
GeneOntologyBiologicalProcess	complement activation, classical pathway	C4A C4B C6 C7 C8B	4.85e-05	44	188	5	GO:0006958
GeneOntologyBiologicalProcess	response to cell cycle checkpoint signaling	ZMPSTE24 MUS81 FBH1	8.53e-05	10	188	3	GO:0072396
GeneOntologyBiologicalProcess	response to DNA integrity checkpoint signaling	ZMPSTE24 MUS81 FBH1	8.53e-05	10	188	3	GO:0072402
GeneOntologyCellularComponent	membrane attack complex	C6 C7 C8B	2.48e-05	7	189	3	GO:0005579
GeneOntologyCellularComponent	nuclear envelope	KLK6 BRIP1 ZMPSTE24 NUP210L INPP4A SYNE1 HTATIP2 PUM2 SCRN1 HOXA7 DST SYNE2 DHRS2 ALOX5 KPNA2	1.83e-04	560	189	15	GO:0005635
GeneOntologyCellularComponent	nuclear membrane	KLK6 BRIP1 ZMPSTE24 INPP4A SYNE1 PUM2 SCRN1 HOXA7 SYNE2 ALOX5 KPNA2	3.50e-04	349	189	11	GO:0031965
Domain	LRR_6	NLRP1 FBXL5 NOD2 NLRP14 PPP1R37 NLRC5	1.90e-05	55	189	6	PF13516
Domain	MACPF_CS	C6 C7 C8B	1.99e-05	6	189	3	IPR020863
Domain	MACPF_2	C6 C7 C8B	3.46e-05	7	189	3	PS51412
Domain	MACPF_1	C6 C7 C8B	3.46e-05	7	189	3	PS00279
Domain	NACHT	NLRP1 NOD2 NLRP14 NLRC5	7.74e-05	23	189	4	PS50837
Domain	NACHT_NTPase	NLRP1 NOD2 NLRP14 NLRC5	7.74e-05	23	189	4	IPR007111
Domain	ACTININ_2	SYNE1 LCP1 DST SYNE2	7.74e-05	23	189	4	PS00020
Domain	ACTININ_1	SYNE1 LCP1 DST SYNE2	7.74e-05	23	189	4	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 LCP1 DST SYNE2	7.74e-05	23	189	4	IPR001589
Domain	-	PUM2 CUL9 FRYL BTAF1 ODAD2 ARMCX1 PKP3 PUM1 HEATR3 KPNA2	9.09e-05	222	189	10	1.25.10.10
Domain	TFIID_sub1_DUF3591	TAF1 TAF1L	1.02e-04	2	189	2	IPR022591
Domain	TBP-binding	TAF1 TAF1L	1.02e-04	2	189	2	PF09247
Domain	Pumilio_RNA-bd	PUM2 PUM1	1.02e-04	2	189	2	IPR033712
Domain	DUF3591	TAF1 TAF1L	1.02e-04	2	189	2	PF12157
Domain	TAF_II_230-bd	TAF1 TAF1L	1.02e-04	2	189	2	IPR009067
Domain	-	TAF1 TAF1L	1.02e-04	2	189	2	1.10.1100.10
Domain	TAF1_animal	TAF1 TAF1L	1.02e-04	2	189	2	IPR011177
Domain	MAC_perforin	C6 C7 C8B	1.16e-04	10	189	3	IPR001862
Domain	MACPF	C6 C7 C8B	1.59e-04	11	189	3	PF01823
Domain	MACPF	C6 C7 C8B	2.10e-04	12	189	3	IPR020864
Domain	MACPF	C6 C7 C8B	2.10e-04	12	189	3	SM00457
Domain	PUF	PUM2 PUM1	3.04e-04	3	189	2	PF00806
Domain	PUM_HD	PUM2 PUM1	3.04e-04	3	189	2	PS50303
Domain	KINESIN_LIGHT	KLC2 KLC1	3.04e-04	3	189	2	PS01160
Domain	PUM-HD	PUM2 PUM1	3.04e-04	3	189	2	IPR033133
Domain	Kinesin_light_repeat	KLC2 KLC1	3.04e-04	3	189	2	IPR015792
Domain	ARM-like	PUM2 CUL9 FRYL BTAF1 ODAD2 ARMCX1 PKP3 PUM1 HEATR3 KPNA2	4.40e-04	270	189	10	IPR011989
Domain	CH	SYNE1 LCP1 DST SYNE2 MICAL3	5.08e-04	65	189	5	SM00033
Domain	DEATH-like_dom	NLRP1 CARD10 NOD2 NLRP14 ANKDD1A KLC1	5.10e-04	99	189	6	IPR011029
Domain	Pkinase_C	AKT3 RPS6KB2 AKT2 STK38L	5.17e-04	37	189	4	IPR017892
Domain	FacI_MAC	C6 C7	6.03e-04	4	189	2	IPR003884
Domain	KASH	SYNE1 SYNE2	6.03e-04	4	189	2	IPR012315
Domain	KASH	SYNE1 SYNE2	6.03e-04	4	189	2	PS51049
Domain	Kinesin_light	KLC2 KLC1	6.03e-04	4	189	2	IPR002151
Domain	PUM	PUM2 PUM1	6.03e-04	4	189	2	PS50302
Domain	KASH	SYNE1 SYNE2	6.03e-04	4	189	2	SM01249
Domain	Pumilio_RNA-bd_rpt	PUM2 PUM1	6.03e-04	4	189	2	IPR001313
Domain	KASH	SYNE1 SYNE2	6.03e-04	4	189	2	PF10541
Domain	FIMAC	C6 C7	6.03e-04	4	189	2	SM00057
Domain	Pumilio	PUM2 PUM1	6.03e-04	4	189	2	SM00025
Domain	ARM-type_fold	PUM2 CUL9 FRYL BTAF1 ODAD2 ARMCX1 FOCAD PKP3 PUM1 HEATR3 KPNA2	6.97e-04	339	189	11	IPR016024
Domain	LDLR_class-A_CS	LRP6 C6 C7 C8B	6.98e-04	40	189	4	IPR023415
Domain	ARM_REPEAT	ODAD2 ARMCX1 PKP3 KPNA2	6.98e-04	40	189	4	PS50176
Domain	ARM	ODAD2 ARMCX1 PKP3 KPNA2	6.98e-04	40	189	4	SM00185
Domain	CH	SYNE1 LCP1 DST SYNE2 MICAL3	7.15e-04	70	189	5	PF00307
Domain	-	SYNE1 LCP1 DST SYNE2 MICAL3	7.63e-04	71	189	5	1.10.418.10
Domain	Pkinase_C	AKT3 RPS6KB2 AKT2 STK38L	8.42e-04	42	189	4	PF00433
Domain	CH	SYNE1 LCP1 DST SYNE2 MICAL3	8.66e-04	73	189	5	PS50021
Domain	CH-domain	SYNE1 LCP1 DST SYNE2 MICAL3	9.79e-04	75	189	5	IPR001715
Domain	Anaphylatoxin_comp_syst	C4A C4B	9.98e-04	5	189	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	9.98e-04	5	189	2	IPR001840
Domain	Ldl_recept_a	LRP6 C6 C7 C8B	1.09e-03	45	189	4	PF00057
Domain	Armadillo	ODAD2 ARMCX1 PKP3 KPNA2	1.29e-03	47	189	4	IPR000225
Domain	LDLRA_1	LRP6 C6 C7 C8B	1.40e-03	48	189	4	PS01209
Domain	Ankyrin_rpt	ANKRD31 LRRK1 IBTK ASB11 ANKDD1A OSBPL1A EHMT1 EXO1 TANC1	1.43e-03	262	189	9	IPR002110
Domain	Rab5-bind	KLC2 KLC1	1.49e-03	6	189	2	PF09311
Domain	Hydantoinase/dihydroPyrase	DPYS DPYSL5	1.49e-03	6	189	2	IPR011778
Domain	Rabaptin_Rab5-bd_dom	KLC2 KLC1	1.49e-03	6	189	2	IPR015390
Domain	TPR_10	KLC2 KLC1	1.49e-03	6	189	2	PF13374
Domain	LDrepeatLR_classA_rpt	LRP6 C6 C7 C8B	1.51e-03	49	189	4	IPR002172
Domain	LDLa	LRP6 C6 C7 C8B	1.51e-03	49	189	4	SM00192
Domain	LDLRA_2	LRP6 C6 C7 C8B	1.51e-03	49	189	4	PS50068
Domain	-	BRIP1 MYO19 NLRP1 CARD10 BTAF1 LRRK1 RFC3 TUFM NOD2 ARL6 NLRP14 FBH1 NLRC5 DLG1 RND2 GIMAP6 RAD54L	1.55e-03	746	189	17	3.40.50.300
Domain	Spectrin	SYNE1 DST SYNE2	1.56e-03	23	189	3	PF00435
Domain	Ank_2	ANKRD31 LRRK1 IBTK ASB11 ANKDD1A OSBPL1A EHMT1 TANC1	1.59e-03	215	189	8	PF12796
Domain	ANATO	C4A C4B	2.07e-03	7	189	2	SM00104
Domain	APC_su10/DOC_dom	HECTD3 CUL9	2.07e-03	7	189	2	IPR004939
Domain	DOC	HECTD3 CUL9	2.07e-03	7	189	2	PS51284
Domain	Cullin_CS	CUL4B CUL9	2.07e-03	7	189	2	IPR016157
Domain	ANAPHYLATOXIN_2	C4A C4B	2.07e-03	7	189	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	2.07e-03	7	189	2	PS01177
Domain	ANAPC10	HECTD3 CUL9	2.07e-03	7	189	2	PF03256
Domain	ANATO	C4A C4B	2.07e-03	7	189	2	PF01821
Domain	APC10	HECTD3 CUL9	2.07e-03	7	189	2	SM01337
Domain	Anaphylatoxin/fibulin	C4A C4B	2.07e-03	7	189	2	IPR000020
Domain	Ank	ANKRD31 LRRK1 IBTK ASB11 ANKDD1A OSBPL1A EHMT1 TANC1	2.29e-03	228	189	8	PF00023
Domain	P-loop_NTPase	BRIP1 CENPE MYO19 NLRP1 CARD10 BTAF1 LRRK1 RFC3 TUFM NOD2 ARL6 NLRP14 FBH1 NLRC5 DLG1 RND2 GIMAP6 RAD54L	2.47e-03	848	189	18	IPR027417
Domain	AGC-kinase_C	AKT3 RPS6KB2 AKT2 STK38L	2.47e-03	56	189	4	IPR000961
Domain	AGC_KINASE_CTER	AKT3 RPS6KB2 AKT2 STK38L	2.47e-03	56	189	4	PS51285
Domain	S_TK_X	AKT3 RPS6KB2 AKT2 STK38L	2.47e-03	56	189	4	SM00133
Domain	HECT	HECW1 HECTD3 HERC4	2.49e-03	27	189	3	PF00632
Domain	HECTc	HECW1 HECTD3 HERC4	2.49e-03	27	189	3	SM00119
Domain	HECT_dom	HECW1 HECTD3 HERC4	2.49e-03	27	189	3	IPR000569
Domain	HECT	HECW1 HECTD3 HERC4	2.49e-03	27	189	3	PS50237
Domain	-	NLRP1 CARD10 NOD2 NLRP14 ANKDD1A	2.55e-03	93	189	5	1.10.533.10
Domain	Cullin_neddylation_domain	CUL4B CUL9	2.74e-03	8	189	2	IPR019559
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	2.74e-03	8	189	2	IPR019565
Domain	Cullin_Nedd8	CUL4B CUL9	2.74e-03	8	189	2	PF10557
Domain	Cullin_Nedd8	CUL4B CUL9	2.74e-03	8	189	2	SM00884
Domain	-	DPYS DPYSL5	2.74e-03	8	189	2	2.30.40.10
Domain	Thiol-ester_cl	C4A C4B	2.74e-03	8	189	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	2.74e-03	8	189	2	IPR019742
Domain	CARD	NLRP1 CARD10 NOD2	2.77e-03	28	189	3	PF00619
Domain	Spectrin_repeat	SYNE1 DST SYNE2	3.07e-03	29	189	3	IPR002017
Domain	Cullin_homology	CUL4B CUL9	3.50e-03	9	189	2	IPR016158
Domain	Arm	ODAD2 PKP3 KPNA2	3.72e-03	31	189	3	PF00514
Domain	CARD	NLRP1 CARD10 NOD2	3.72e-03	31	189	3	IPR001315
Domain	-	ANKRD31 LRRK1 IBTK ASB11 ANKDD1A OSBPL1A EHMT1 TANC1	3.83e-03	248	189	8	1.25.40.20
Domain	SPEC	SYNE1 DST SYNE2	4.08e-03	32	189	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 DST SYNE2	4.08e-03	32	189	3	IPR018159
Pathway	WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY	C4A C4B C6 C7 C8B	6.66e-07	17	148	5	MM15944
Pathway	WP_COMPLEMENT_ACTIVATION	C4A C4B C6 C7 C8B	2.72e-06	22	148	5	M39502
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C6 C7	3.64e-06	11	148	4	MM1430
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B C6 C7	5.41e-06	12	148	4	MM1368
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	AKT3 BRIP1 RFC3 CCNG1 L3MBTL1 EHMT1 EXO1 AKT2 TAF1 TAF1L	6.02e-06	157	148	10	MM15226
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	AKT3 BRIP1 RFC3 CCNG1 L3MBTL1 EHMT1 EXO1 AKT2 TAF1 TAF1L	7.12e-06	160	148	10	M27498
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C6 C7	7.75e-06	13	148	4	M4732
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B C6 C7	1.46e-05	15	148	4	M7146
Pathway	BIOCARTA_COMP_PATHWAY	C4A C4B C6 C7	2.50e-05	17	148	4	MM1369
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	3.85e-05	7	148	3	M47407
Pathway	KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION	C6 C7 C8B	3.85e-05	7	148	3	M47873
Pathway	BIOCARTA_COMP_PATHWAY	C4A C4B C6 C7	4.96e-05	20	148	4	M917
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	C6 C7 C8B	6.11e-05	8	148	3	MM14656
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	C6 C7 C8B	6.11e-05	8	148	3	M27006
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT3 MET AKT2	9.09e-05	9	148	3	M47402
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION	C6 C7 C8B	9.09e-05	9	148	3	M47881
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT3 MET AKT2	9.09e-05	9	148	3	M47490
Pathway	KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	1.29e-04	10	148	3	M47400
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY	AKT3 MET AKT2	1.29e-04	10	148	3	M47401
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	AKT3 RPS6KB2 AKT2	1.29e-04	10	148	3	M27095
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	AKT3 RPS6KB2 AKT2	1.29e-04	10	148	3	MM14778
Pathway	WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY	AKT3 GANC DDR2 DIO2 AKT2	1.73e-04	50	148	5	M48087
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	1.76e-04	11	148	3	M47403
Pathway	KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	1.76e-04	11	148	3	M47484
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	1.76e-04	11	148	3	M47499
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	1.76e-04	11	148	3	M47501
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	2.33e-04	12	148	3	M47393
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	3.00e-04	13	148	3	M47398
Pathway	KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY	AKT3 RPS6KB2 AKT2	4.70e-04	15	148	3	M47663
Pathway	WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE	C6 C7 VCAM1	6.92e-04	17	148	3	M39733
Pathway	BIOCARTA_LAIR_PATHWAY	C6 C7 VCAM1	6.92e-04	17	148	3	M3952
Pathway	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	C4A C4B C6 C7 C8B	7.81e-04	69	148	5	M16894
Pathway	KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY	AKT3 AKT2	1.07e-03	5	148	2	M48999
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	IMPDH2 HECTD3 MYO19 MPDZ BTAF1 RRBP1 JMJD1C TUFM EXOC8 PREB PRR12 IBTK DST DLG1 C4A MICAL3 C4B TANC1 CRYBG3 HSD17B11 HEATR3	8.59e-11	650	190	21	38777146
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CUL4B HECW1 SYNE1 PUM2 SCRN1 ALPK1 RRBP1 DSCAML1 DST SYNE2 EHMT1 AKAP11 STK38L	3.98e-10	225	190	13	12168954
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP22 DPYSL5 KLC2 MPDZ FRYL ALPK1 KIAA1671 CDCA2 CCDC88C DST PI4KB SYNE2 EXO1 PLEKHA1 AKAP11 TANC1 USP54 CRYBG3 PUM1 KLC1	6.34e-08	861	190	20	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRAF7 MAN2A2 NSD1 MUS81 CUL9 CARD10 FRYL BTAF1 LRRK1 NOD2 FOCAD PRR12 CCDC88C DST EHMT1 NLRC5 MLLT6 AKT2 MICAL3 TANC1 PUM1 ALOX5	1.95e-07	1105	190	22	35748872
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BRIP1 NSD1 BTAF1 RFC3 ARHGAP11A JMJD1C MYSM1 CDCA2 ZNF12 MGMT EHMT1 MLLT6 TAF1 DEK TOP2B KPNA2	2.73e-07	608	190	16	36089195
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CRISP2 USP22 CENPE TOPAZ1 MYO19 ARHGAP11A DSCAML1 TUFM KIAA1671 FOCAD KDM4D LOXHD1 DST PLXNA4 C6 ALOX5 HEATR3	7.02e-07	736	190	17	29676528
Pubmed	The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues.	C6 C7 C8B	1.59e-06	5	190	3	10551839
Pubmed	FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress.	MUS81 BTAF1 FBH1	1.59e-06	5	190	3	23361013
Pubmed	Predominant role for C5b-9 in renal ischemia/reperfusion injury.	C4A C4B C6	1.59e-06	5	190	3	10811844
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	IMPDH2 HECTD3 SYNE1 MPDZ RRBP1 PREPL DCAF5 PREB MET PMPCA SYNE2 EHMT1 OCIAD2 PLEKHA1 DLG1 AKAP11 AKT2 TANC1 CRYBG3 DEK DNAJC3 VPS13B TOP2B KLC1	2.21e-06	1487	190	24	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FNBP1 TUT4 INPP4A DPYSL5 FRYL BTAF1 RRBP1 PCGF3 MEF2A JMJD1C KIAA1671 BCAP29 PKP3 MKLN1 EHMT1 NLRC5 DLG1 LUZP2 MICAL3 TANC1 STK38L DNAJC3 VPS13B RPAP2	2.26e-06	1489	190	24	28611215
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MPDZ RRBP1 KIAA1671 IBTK DST AKAP11 MICAL3 TANC1 CRYBG3	2.47e-06	209	190	9	36779422
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TRAF7 USP22 RPS6KB2 DDR2 AZI2 RRBP1 PCGF3 PREB MET DST RALBP1 AKAP11 AKT2 STK38L TAF1L DEK PCDH18 KLC1	2.94e-06	910	190	18	36736316
Pubmed	Genomic analysis of mouse retinal development.	MAN2A2 USP22 ZNF254 NSD1 CUL9 FRYL RFC3 ARHGAP11A CRABP1 MEF2A CEP164 CDCA2 OSBP DST DIO2 LRP6 SMN1 PUM1 ARHGAP11B	3.00e-06	1006	190	19	15226823
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	CUL4B TUT4 BRIP1 CENPE RNF149 MPDZ PUM2 RRBP1 JMJD1C IBTK DLG1 AKT2 TANC1 USP54 PUM1 RPAP2	3.11e-06	733	190	16	34672954
Pubmed	Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9.	C6 C7 C8B	3.17e-06	6	190	3	22832194
Pubmed	Human transcription factor protein interaction networks.	ZMPSTE24 USP22 IMPDH2 ACO2 PUM2 CUL9 PCGF3 MEF2A JMJD1C DCAF5 KIAA1671 CDCA2 PRR12 DST SYNE2 EHMT1 LRP6 MLLT6 SMN1 TAF1 USP54 PUM1 TAF1L	3.83e-06	1429	190	23	35140242
Pubmed	The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport.	APBA2 KLC2 KLC1	5.53e-06	7	190	3	17332754
Pubmed	CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers.	C6 C7 C8B	5.53e-06	7	190	3	30552328
Pubmed	Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.	C6 C7 C8B	5.53e-06	7	190	3	19864026
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KLC2 MPDZ FRYL KIAA1671 CCDC88C DST PI4KB EXO1 PLEKHA1 USP54 PUM1 STK38L	7.09e-06	446	190	12	24255178
Pubmed	Molecular organization and function of the complement system.	C6 C7 C8B	8.81e-06	8	190	3	3052276
Pubmed	Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes.	HTATIP2 APBA2 MEF2A LUZP2	1.17e-05	26	190	4	16280085
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	IMPDH2 SYNE1 PARP2 MPDZ RFC3 IBTK PKP3 EHMT1 DEK TOP2B	1.20e-05	321	190	10	32098917
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	LRRC32 ALPK1 LCP1 GFI1 HOXA7 PRR12 LOXHD1 L3MBTL1 BCAP29 NLRC5 AKAP11 MICAL3 TAF1	1.22e-05	552	190	13	10737800
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CUL4B TRAF7 TUT4 USP22 HECTD3 HTATIP2 APBA2 CUL9 RFC3 DCAF5 TUFM KIAA1671 ASB11 EHMT1 TANC1 TAF1 USP54 CRYBG3 RPAP2	1.30e-05	1116	190	19	31753913
Pubmed	Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.	C6 C7 C8B	1.32e-05	9	190	3	19162005
Pubmed	Gene expression analysis of the embryonic subplate.	SCRN1 LCP1 ARHGAP11A CRABP1 SYNE2 PLXNA4 TACC3 ARHGAP11B	1.33e-05	196	190	8	21862448
Pubmed	New nomenclature for chromatin-modifying enzymes.	NSD1 KDM4D EHMT1 TAF1 TAF1L	1.53e-05	57	190	5	18022353
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FNIP2 FNBP1 SYNE1 PUM2 CUL9 CNKSR2 DCAF5 FOCAD MICAL3 PUM1 VPS13B	1.65e-05	407	190	11	12693553
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	TUT4 KLC2 RRBP1 LCP1 TUFM FOCAD OSBP NLRP14 ATP8A1 DLG1 KLC1	1.81e-05	411	190	11	36652389
Pubmed	Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.	C4A C4B C6	1.87e-05	10	190	3	30429287
Pubmed	Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle.	SYNE1 SYNE2 KLC1	1.87e-05	10	190	3	28533284
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HID1 KIAA1671 BLMH CDCA2 PMPCA SYNE2 PPP1R37 LRP6 UBR3 PLEKHA1 DLG1 MICAL3 TANC1 CRYBG3 PUM1 STX16 DEK KPNA2	2.01e-05	1049	190	18	27880917
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CUL4B CENPE DPYSL5 KLC2 AZI2 LCP1 CEP164 TSFM KIAA1671 CCDC88C IBTK MICAL3 TANC1 TFB2M USP54 KLC1	2.04e-05	853	190	16	28718761
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CENPE TOPAZ1 DPYSL5 KLC2 RRBP1 LCP1 LOXHD1 C4A MICAL3 C4B RP1 PUM1	2.08e-05	497	190	12	36774506
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TUT4 CENPE SYNE1 ACO2 MYO19 PUM2 RRBP1 PREPL TUFM TSFM PREB KIAA1671 IBTK DST PMPCA HIBCH SYNE2 OCIAD2 AKAP11 TANC1 CRYBG3 VPS13B	2.54e-05	1496	190	22	32877691
Pubmed	Do Gametes Woo? Evidence for Their Nonrandom Union at Fertilization.	DND1 LRP6 PUM1	2.56e-05	11	190	3	28978771
Pubmed	Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins.	KDM4D L3MBTL1 EHMT1	2.56e-05	11	190	3	19144645
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CUL4B FNBP1 BRIP1 KLC2 PUM2 BTAF1 RRBP1 OSBP MGMT PKP3 EXO1 DLG1 MICAL3 TACC3 TOP2B	2.57e-05	774	190	15	15302935
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	2.97e-05	2	190	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	2.97e-05	2	190	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	2.97e-05	2	190	2	15998580
Pubmed	Akt2 and Akt3 play a pivotal role in malignant gliomas.	AKT3 AKT2	2.97e-05	2	190	2	20167810
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	2.97e-05	2	190	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	2.97e-05	2	190	2	19933335
Pubmed	Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers.	ARHGAP11A ARHGAP11B	2.97e-05	2	190	2	38046902
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	2.97e-05	2	190	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	2.97e-05	2	190	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	2.97e-05	2	190	2	12207352
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	2.97e-05	2	190	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	2.97e-05	2	190	2	22387014
Pubmed	Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.	SYNE1 SYNE2	2.97e-05	2	190	2	11792814
Pubmed	Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.	PUM2 PUM1	2.97e-05	2	190	2	12459267
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	2.97e-05	2	190	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	2.97e-05	2	190	2	23918728
Pubmed	Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.	PUM2 PUM1	2.97e-05	2	190	2	29165587
Pubmed	Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.	SYNE1 SYNE2	2.97e-05	2	190	2	24931616
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	2.97e-05	2	190	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	2.97e-05	2	190	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	2.97e-05	2	190	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	2.97e-05	2	190	2	6950384
Pubmed	Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.	TUFM TSFM	2.97e-05	2	190	2	17033963
Pubmed	PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.	PUM2 PUM1	2.97e-05	2	190	2	35507203
Pubmed	Bespoke RNA recognition by Pumilios.	PUM2 PUM1	2.97e-05	2	190	2	26517885
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	2.97e-05	2	190	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	2.97e-05	2	190	2	8428773
Pubmed	Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.	PUM2 PUM1	2.97e-05	2	190	2	12667987
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	2.97e-05	2	190	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	2.97e-05	2	190	2	21345967
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	2.97e-05	2	190	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	2.97e-05	2	190	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	2.97e-05	2	190	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	2.97e-05	2	190	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	2.97e-05	2	190	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	2.97e-05	2	190	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	2.97e-05	2	190	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	2.97e-05	2	190	2	17728371
Pubmed	Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.	TAF1 TAF1L	2.97e-05	2	190	2	38804708
Pubmed	Structure and organization of the C4 genes.	C4A C4B	2.97e-05	2	190	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	2.97e-05	2	190	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	2.97e-05	2	190	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	2.97e-05	2	190	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	2.97e-05	2	190	2	2387317
Pubmed	A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.	PUM2 PUM1	2.97e-05	2	190	2	31078383
Pubmed	Sustained expression of a neuron-specific isoform of the Taf1 gene in development stages and aging in mice.	TAF1 TAF1L	2.97e-05	2	190	2	22842574
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	2.97e-05	2	190	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	2.97e-05	2	190	2	7365238
Pubmed	Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.	PUM2 PUM1	2.97e-05	2	190	2	32753408
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	2.97e-05	2	190	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	2.97e-05	2	190	2	17971360
Pubmed	Crystal structures of the tetratricopeptide repeat domains of kinesin light chains: insight into cargo recognition mechanisms.	KLC2 KLC1	2.97e-05	2	190	2	22470497
Pubmed	Linkage between complement components 6 and 7 and glutamic pyruvate transaminase in the marsupial Monodelphis domestica.	C6 C7	2.97e-05	2	190	2	8259924
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	2.97e-05	2	190	2	29928053
Pubmed	Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.	TAF1 TAF1L	2.97e-05	2	190	2	27571988
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	2.97e-05	2	190	2	17971229
Pubmed	Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.	TAF1 TAF1L	2.97e-05	2	190	2	34403156
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	2.97e-05	2	190	2	6881182
Pubmed	Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.	PUM2 PUM1	2.97e-05	2	190	2	32437472
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	2.97e-05	2	190	2	17921792
Interaction	SFN interactions	IMPDH2 KLC2 FRYL ARHGAP11A KIAA1671 BLMH CCDC88C MET OSBP DST PI4KB PKP3 EXO1 PLEKHA1 AKAP11 TANC1 USP54 CRYBG3 PUM1 DEK KLC1	2.53e-06	692	190	21	int:SFN
GeneFamily	Complement system\|Sushi domain containing	C4A C4B C6 C7 C8B	5.40e-06	36	129	5	492
GeneFamily	NLR family	NLRP1 NOD2 NLRP14 NLRC5	2.79e-05	25	129	4	666
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ODAD2 ARMCX1 PKP3 KPNA2	2.46e-04	43	129	4	409
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE2	3.00e-04	4	129	2	1252
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	NLRP1 CARD10 NOD2	1.25e-03	30	129	3	959
GeneFamily	Cullins	CUL4B CUL9	1.38e-03	8	129	2	1032
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC39C KLC2 TANC1 DNAJC3 KLC1	1.40e-03	115	129	5	769
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	1.76e-03	9	129	2	1234
GeneFamily	Ankyrin repeat domain containing	ANKRD31 IBTK ASB11 ANKDD1A OSBPL1A EHMT1 TANC1	1.77e-03	242	129	7	403
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBP OSBPL1A	3.18e-03	12	129	2	670
GeneFamily	ATPase phospholipid transporting	ATP8A2 ATP8A1	4.99e-03	15	129	2	1210
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TUT4 CENPE DDR2 PUM2 FRYL BTAF1 ARHGAP11A MEF2A IBTK DST SYNE2 MKLN1 DLG1 AKAP11 MICAL3 CRYBG3 PUM1 DEK HERC4 VPS13B KLC1	1.19e-06	856	190	21	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FNBP1 TUT4 MAN2A2 INPP4A SYNE1 TTC39C RNF149 APBA2 NSD1 PUM2 NLRP1 FRYL BTAF1 LCP1 JMJD1C GFI1 DCAF5 MYSM1 CCDC88C ATP8A1 NLRC5 MLLT6 AKAP11 STX16 DEK GIMAP6 VPS13B TOP2B KLC1	1.20e-06	1492	190	29	M40023
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	BRIP1 CENPE TENT5C ARHGAP11A CDCA2 EXO1 TACC3 HSD17B11 VCAM1 KPNA2	1.36e-06	190	190	10	M761
Coexpression	GABRIELY_MIR21_TARGETS	FNBP1 DDR2 MPDZ SCRN1 EXOC8 FBXL5 CCNG1 SYNE2 ZNF667 UBR3 DLG1 TAF1	1.46e-06	289	190	12	M2196
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	TUT4 MAN2A2 SYNE1 NLRP1 FRYL CCNG1 ATP8A1 PLEKHA1 DLG1 TAF1	2.06e-06	199	190	10	M7607
Coexpression	LI_WILMS_TUMOR_ANAPLASTIC_UP	RFC3 PCGF3 RAD54L KPNA2	5.91e-06	17	190	4	M1215
Coexpression	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	BRIP1 CENPE ZNF273 ZNF254 RFC3 ARHGAP11A CDCA2 MET BCAP29 SYNE2 CNPY3 ZNF91 STK38L RAD54L	6.30e-06	454	190	14	M19927
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_UP	HTATIP2 RRBP1 ITGA7 LCP1 ARHGAP11A CEP164 HOXA7 BCAP29 PI4KB OSBPL1A CNPY3 AKT2 KLC1	1.31e-05	420	190	13	M3053
Coexpression	TRAVAGLINI_LUNG_CILIATED_CELL	CERKL CRISP2 ZNF273 LYPLA2 SYNE1 TTC39C MPDZ AZI2 ODAD2 DALRD3 CEP164 TUFM GSN FOCAD ARL6 CCDC88C MGMT DAW1 SYNE2 CNPY3 RP1 C6	1.55e-05	1093	190	22	M41649
Coexpression	GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	BRIP1 ZMPSTE24 IMPDH2 CENPE CARD10 ARHGAP11A TSPAN2 FOCAD ZNF667	1.57e-05	199	190	9	M6203
Coexpression	GSE20715_WT_VS_TLR4_KO_LUNG_DN	SYNE1 BLMH USP26 CCDC88C IBTK ATF7IP2 PPP1R37 C4B VCAM1	1.57e-05	199	190	9	M4350
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	GANC CENPE PCGF3 TBC1D8B MEF2A JMJD1C DCAF5 DLG1 STK38L	1.64e-05	200	190	9	M5963
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	BRIP1 MYO19 TENT5C RFC3 ARHGAP11A GFRA1 CDCA2 EXO1 DHRS2 TACC3 RAD54L	2.58e-05	323	190	11	M2156
Coexpression	LA_MEN1_TARGETS	DDR2 AZI2 CRABP1 HSD17B11	3.00e-05	25	190	4	M1182
Coexpression	LA_MEN1_TARGETS	DDR2 AZI2 CRABP1 HSD17B11	4.12e-05	27	190	4	MM518
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	IMPDH2 SYNE1 TENT5C BTAF1 AZI2 TBC1D8B EHMT1 TANC1	6.20e-05	184	190	8	M9005
Coexpression	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	CNKSR2 AZI2 ARMCX1 ATF7IP2 LRP6 TAF1 STX16 ZNF682	7.76e-05	190	190	8	M4674
Coexpression	WENDT_COHESIN_TARGETS_UP	MEF2A JMJD1C MKLN1 TOP2B	8.21e-05	32	190	4	M10024
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	TUT4 ZMPSTE24 IMPDH2 HECTD3 LYPLA2 FRYL BTAF1 AZI2 PCGF3 DALRD3 MYSM1 KDM4D PLEKHA1 TACC3 PUM1 HERC4 TOP2B	8.74e-05	807	190	17	M14594
Coexpression	GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	CENPE RFC3 GFI1 GFRA1 TSPAN2 CDCA2 EXO1 KPNA2	1.07e-04	199	190	8	M6205
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	ITGA7 DND1 GFI1 CEP164 HOXA7 EXO1 MICAL3 RAD54L	1.11e-04	200	190	8	M8039
Coexpression	GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP	USP22 GSN CCDC88C PKP3 AHSG UBR3 PLEKHA1 KPNA2	1.11e-04	200	190	8	M7053
Coexpression	GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	ATP8A2 SYNE1 DDR2 RNF149 GSN RALBP1 TANC1 PMFBP1	1.11e-04	200	190	8	M7028
Coexpression	GSE27786_LIN_NEG_VS_BCELL_DN	TUT4 LYPLA2 TRIM39 CEP164 FBXL5 CCDC88C SYNE2 HSD17B11	1.11e-04	200	190	8	M4768
Coexpression	GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	AKT3 TUT4 LYPLA2 MUS81 CCDC88C MLLT6 STX16 KLHL4	1.11e-04	200	190	8	M5059
Coexpression	GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	CRISP2 TBC1D8B MEF2A IBTK OSBPL1A MKLN1 TFB2M STK38L	1.11e-04	200	190	8	M5763
Coexpression	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	LCP1 CCNG1 BCAP29 EXO1 USP54 RAD54L KPNA2	1.31e-04	153	190	7	M438
Coexpression	GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS	ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L	1.32e-04	107	190	6	M39165
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	SYNE1 NSD1 TRIM39 JMJD1C ATP8A1 NLRC5 PLEKHA1	1.60e-04	158	190	7	M372
Coexpression	TOMLINS_PROSTATE_CANCER_DN	SCRN1 GSN DST C7	1.99e-04	40	190	4	M11504
Coexpression	NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP	ZMPSTE24 AZI2 PREPL PREB HOXA7 CCDC88C IBTK BCAP29 DLG1 STK38L GIMAP6 HEATR3	2.01e-04	477	190	12	M40930
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 SYNE2 EXO1 TACC3 DEK ARHGAP11B KPNA2	1.10e-09	200	190	11	0d9b8d51a7630e70e60c76c763ff82df4c559152
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells\|2m / Sample Type, Dataset, Time_group, and Cell type.	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 SYNE2 EXO1 TACC3 DEK ARHGAP11B KPNA2	1.10e-09	200	190	11	0675f580ccef705875854247bbfd4ee2bcf126a1
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 DHRS2 TACC3 DEK RAD54L	1.19e-08	194	190	10	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|B_lymphocytes / Location, Cell class and cell subclass	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L KPNA2	1.45e-08	198	190	10	41e4bc7964a4895dd05bc62f0ef632ce9c89e34f
ToppCell	10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK RAD54L KPNA2	1.52e-08	199	190	10	dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L KPNA2	1.60e-08	200	190	10	8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2
ToppCell	LAM-Myeloid-pMacrophage\|Myeloid / Condition, Lineage and Cell class	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	1.60e-08	200	190	10	0078d56337d44074326e8ccd1d412d098d86eeab
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L KPNA2	1.60e-08	200	190	10	55501f83409e0174c756a13ad8077f5b59975e27
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells\|6m / Sample Type, Dataset, Time_group, and Cell type.	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L KPNA2	1.60e-08	200	190	10	b9aad527d3ad5bc701e93fa2afdebf695b2a74bb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE LCP1 ARHGAP11A NOD2 SKOR2 EXO1 TACC3 RAD54L	4.93e-08	169	190	9	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMPSTE24 CENPE SYNE1 CARD10 CDCA2 SYNE2 TACC3 ALOX5 VCAM1	8.88e-08	181	190	9	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMPSTE24 CENPE SYNE1 CARD10 CDCA2 SYNE2 TACC3 ALOX5 VCAM1	8.88e-08	181	190	9	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 MICAL3 TACC3 ARHGAP11B RAD54L	1.07e-07	185	190	9	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE LCP1 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.34e-07	190	190	9	185ae04c68f825cd346aa65072cc5da6a39dff4a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE LCP1 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.34e-07	190	190	9	e38dc41f2e79e3bd51326581c6ebe51927edb549
ToppCell	Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	1.68e-07	195	190	9	79ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	BRIP1 CENPE RFC3 LCP1 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.68e-07	195	190	9	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 TACC3 ARHGAP11B RAD54L KPNA2	1.68e-07	195	190	9	75759fd7f925725f0ecd07214afcca5aa2158f9e
ToppCell	Dividing_cells-Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	1.68e-07	195	190	9	19829760dfcc0edafd2a2bd80f424a45d039af1f
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L	1.68e-07	195	190	9	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	BRIP1 CENPE DDR2 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.75e-07	196	190	9	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.83e-07	197	190	9	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	Healthy_Control-Lymphoid-T-Proliferating_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.83e-07	197	190	9	3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L	1.99e-07	199	190	9	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CERKL BRIP1 CENPE ARHGAP11A CDCA2 SYNE2 EXO1 TACC3 RAD54L	1.99e-07	199	190	9	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	tumor_Lung-T/NK_cells-Undetermined\|tumor_Lung / Location, Cell class and cell subclass	CENPE ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L KPNA2	1.99e-07	199	190	9	2e222e2e080bc2be63d0fdf285e1790676b911ef
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L	2.08e-07	200	190	9	2938a029fa0478be561574ace91f95c4a528b2d4
ToppCell	Biopsy_Control_(H.)-Immune-Proliferating_Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	2.08e-07	200	190	9	ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 CENPE MYO19 RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.08e-07	200	190	9	2afbb5b5742b956993796621fea7e0c9888754a1
ToppCell	LAM-Myeloid-pMacrophage\|LAM / Condition, Lineage and Cell class	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	2.08e-07	200	190	9	7e233d037165c9d3607604aaaf0f368e266567d3
ToppCell	Biopsy_IPF-Immune-Proliferating_Macrophages\|Biopsy_IPF / Sample group, Lineage and Cell type	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	2.08e-07	200	190	9	8abb2c25422717e994468ac02d8260344341467f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells\|3m / Sample Type, Dataset, Time_group, and Cell type.	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L	2.08e-07	200	190	9	cfe017b4a4d604a553d0a3df9659687f38e9a7af
ToppCell	NS-critical-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 ARHGAP11B RAD54L KPNA2	2.08e-07	200	190	9	7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 CENPE MYO19 RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.08e-07	200	190	9	4462ebd5d4632788f10a93fadd2babae701c754f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B KPNA2	2.08e-07	200	190	9	38665128b54f4a81b53c961427aed67bf4e2510b
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 DEK ARHGAP11B RAD54L	2.08e-07	200	190	9	8f9e76048ae6f45218a09a95a2c4b31e8a8937b2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 LCP1 TBC1D8B TSPAN2 SYNE2 NLRC5 MLLT6 RPAP2	4.29e-07	159	190	8	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	6.82e-07	169	190	8	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	Dividing_Macrophages-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B PMFBP1 KPNA2	6.82e-07	169	190	8	eb0c993ef2eea73bc4881182520922ce9ae9368f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MET ATP8A1 SYNE2 TANC1 RP1 USP54 DHRS2 ZNF682	7.13e-07	170	190	8	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.10e-06	180	190	8	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPE ARHGAP11A CDCA2 EXO1 TACC3 DEK RAD54L KPNA2	1.14e-06	181	190	8	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.14e-06	181	190	8	e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPE ARHGAP11A CDCA2 EXO1 TACC3 DEK RAD54L KPNA2	1.14e-06	181	190	8	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	P28-Endothelial-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.14e-06	181	190	8	2be3d44619adb25d339e7a27b500a56e07e8de01
ToppCell	CF-Lymphoid-T_cell_&_NK_cell\|CF / Disease state, Lineage and Cell class	TTC39C TENT5C GFI1 CCDC88C OCIAD2 GIMAP6 VCAM1 RPAP2	1.19e-06	182	190	8	a8dfc59a3974e3433f434676b7c2749d0fcfc8b2
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRIP1 CENPE ARHGAP11A CDCA2 HENMT1 EXO1 SYCE1 RAD54L	1.29e-06	184	190	8	eaef1dcde60ba14e2c7fd699d01c225487256d82
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRIP1 CENPE ARHGAP11A CDCA2 HENMT1 EXO1 SYCE1 RAD54L	1.29e-06	184	190	8	bba0138c8f7e3645a688b9a4d12f6f2134ee2c08
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRIP1 CENPE ARHGAP11A CDCA2 HENMT1 EXO1 SYCE1 RAD54L	1.29e-06	184	190	8	fa73738350654066d7f9ebf78359e20ee6cbdd98
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.35e-06	185	190	8	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FNBP1 TTC39C APBA2 NLRP1 LCP1 CCDC88C ATP8A1 NLRC5	1.40e-06	186	190	8	9d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FNBP1 TTC39C APBA2 NLRP1 LCP1 CCDC88C ATP8A1 NLRC5	1.40e-06	186	190	8	bd3bd022b575d9b0ef90d50a5cb874085a827b77
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FNBP1 TTC39C APBA2 NLRP1 LCP1 CCDC88C ATP8A1 NLRC5	1.40e-06	186	190	8	924cc357b4c4ce8e9b05773bdab544f0b65474cc
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	LRRC32 FRYL TSPAN2 KIAA1671 CCDC88C MET ATP8A1 SYNE2	1.46e-06	187	190	8	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.46e-06	187	190	8	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	1.58e-06	189	190	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.64e-06	190	190	8	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	FNBP1 AKT3 TTC39C APBA2 LCP1 CCDC88C SYNE2 NLRC5	1.64e-06	190	190	8	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FNBP1 CENPE LCP1 ARHGAP11A GFI1 CCDC88C SYNE2 DEK	1.71e-06	191	190	8	912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FNBP1 CENPE LCP1 ARHGAP11A GFI1 CCDC88C SYNE2 DEK	1.71e-06	191	190	8	77a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B KPNA2	1.71e-06	191	190	8	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BRIP1 CENPE RFC3 LCP1 CDCA2 EXO1 TACC3 RAD54L	1.71e-06	191	190	8	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.85e-06	193	190	8	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	FNBP1 AKT3 TTC39C APBA2 NLRP1 CCDC88C SYNE2 NLRC5	1.85e-06	193	190	8	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE ARHGAP11A CDCA2 TACC3 ARHGAP11B RAD54L KPNA2	1.85e-06	193	190	8	81e6240cffb094b2aa3684fd0889b6497f47c4f0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRIP1 HECW1 TSPAN2 CDCA2 PLXNA4 EXO1 TACC3 RAD54L	1.85e-06	193	190	8	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRIP1 HECW1 RFC3 CDCA2 PLXNA4 EXO1 TACC3 RAD54L	1.85e-06	193	190	8	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	1.92e-06	194	190	8	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 CENPE ARHGAP11A CDCA2 TACC3 ARHGAP11B RAD54L KPNA2	1.92e-06	194	190	8	1a2090e997c70433d07f56bf7cb0a50c4151118c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 TENT5C GFI1 ATP8A1 SYNE2 NLRC5 OCIAD2 VCAM1	2.00e-06	195	190	8	42382653e977714bff453bece26a6cd66ea2cc1f
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.00e-06	195	190	8	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.00e-06	195	190	8	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 TACC3 ARHGAP11B RAD54L	2.07e-06	196	190	8	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.07e-06	196	190	8	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.07e-06	196	190	8	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	2.07e-06	196	190	8	ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 TSPAN2 CCDC88C HENMT1 ATP8A1 SYNE2 NLRC5 MLLT6	2.07e-06	196	190	8	a2db88fad9bbc55685f8e681d120ef38715ca3c4
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.07e-06	196	190	8	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CENPE ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L KPNA2	2.15e-06	197	190	8	cebf47d66f425c84d3fea962e11f5bf4bfe2e60f
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRIP1 CENPE ARHGAP11A CDCA2 C7 TACC3 VCAM1 RAD54L	2.15e-06	197	190	8	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	T_cells-CTLs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SYNE1 GFI1 TSPAN2 CCDC88C SYNE2 NLRC5 PLEKHA1 MLLT6	2.15e-06	197	190	8	2de34e20915a247bee75aa40495e23c20bb23e18
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.15e-06	197	190	8	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CENPE LRRC32 CARD10 HID1 ARHGAP11A CDCA2 TACC3 GIMAP6	2.15e-06	197	190	8	491e12a5fca06b86443c0173f5fa750ea3b8a715
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.15e-06	197	190	8	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	severe_influenza-NK\|World / disease group, cell group and cell class (v2)	SYNE1 APBA2 GFI1 HENMT1 SYNE2 PLEKHA1 MLLT6 KLHL4	2.15e-06	197	190	8	8e86a1ee0418e153d4f0bf291006cffc6cf36f71
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SYNE1 LCP1 GFI1 CCDC88C SYNE2 NLRC5 MLLT6 GIMAP6	2.24e-06	198	190	8	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	normal_Lung-T/NK_cells-Undetermined\|normal_Lung / Location, Cell class and cell subclass	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 DEK ARHGAP11B RAD54L	2.24e-06	198	190	8	c65cdb54409087014125a76627e5efb5fe8dabc9
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPE ARHGAP11A FBXL5 CDCA2 TACC3 HSD17B11 ARHGAP11B KPNA2	2.24e-06	198	190	8	c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 ARHGAP11B RAD54L	2.24e-06	198	190	8	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	medial-Hematologic-Proliferating_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.24e-06	198	190	8	da6963184c32761c896a9b91a5321ad84b583736
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.24e-06	198	190	8	6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb
ToppCell	medial-2-Hematologic-Proliferating_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.24e-06	198	190	8	64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f
ToppCell	medial-Hematologic-Proliferating_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRIP1 CENPE RFC3 ARHGAP11A CDCA2 EXO1 TACC3 RAD54L	2.24e-06	198	190	8	fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRIP1 CENPE ARHGAP11A CDCA2 EXO1 TACC3 RAD54L KPNA2	2.24e-06	198	190	8	f088badb90c6c2d916195f5649eda102119c9ac6
Drug	dimethyl phosphate	NSD1 TUFM BLMH DST AHSG	2.67e-06	27	190	5	CID000013134
Drug	4-hydroxy-2-nonenal	DDR2 HTATIP2 ALPK1 ITGA7 ARHGAP11A TBC1D8B GSN CDCA2 CCNG1 BMP1 DST ATP8A1 RALBP1 DIO2 ZNF91 TACC3 HSD17B11 DNAJC3 ALOX5 RAD54L KPNA2	3.55e-06	798	190	21	ctd:C027576
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A	HECW1 INPP4A APBA2 TENT5C GFI1 TSFM GSN MET AKT2 STX16	5.64e-06	194	190	10	3854_UP
Disease	Complement deficiency disease	C4A C4B C6 C7 C8B	1.79e-06	33	183	5	C0272242
Disease	Malignant neoplasm of breast	BRIP1 SYNE1 ACO2 RPS6KB2 RNF149 ARHGAP11A GRM6 GSN BMP1 NLRP14 DAW1 SYNE2 EHMT1 EXO1 NLRC5 AKT2 USP54 DEK VPS13B RAD54L	1.27e-05	1074	183	20	C0006142
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	ZMPSTE24 SYNE1 SYNE2	4.95e-05	12	183	3	DOID:11726 (implicated_via_orthology)
Disease	Hydrocephalus	MPDZ CCDC88C	1.14e-04	3	183	2	cv:C0020255
Disease	Congenital hydrocephalus	MPDZ CCDC88C	1.14e-04	3	183	2	cv:C0020256
Disease	cholesterol to total lipids in large VLDL percentage	ANKRD31 LCP1 JMJD1C NLRC5	1.75e-04	45	183	4	EFO_0022236
Disease	triacylglycerol 54:4 measurement	ATP8A2 LCP1 ATF7IP2 LUZP2	1.91e-04	46	183	4	EFO_0010422
Disease	rheumatic myocarditis (is_marker_for)	GSN VCAM1	2.28e-04	4	183	2	DOID:8481 (is_marker_for)
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	2.28e-04	4	183	2	cv:CN293514
Disease	cholesteryl esters to total lipids in small VLDL percentage	ANKRD31 LCP1 JMJD1C NLRC5	2.44e-04	49	183	4	EFO_0022256
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 LCP1 JMJD1C NLRC5	2.85e-04	51	183	4	EFO_0022242
Disease	sarcoma (is_marker_for)	CCNG1 MET	3.78e-04	5	183	2	DOID:1115 (is_marker_for)
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	3.78e-04	5	183	2	C1450051
Disease	relapsing-remitting multiple sclerosis (is_implicated_in)	NOD2 KLC1	3.78e-04	5	183	2	DOID:2378 (is_implicated_in)
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	3.78e-04	5	183	2	C0410190
Disease	Lipodystrophy	ZMPSTE24 PARP2	3.78e-04	5	183	2	C0023787
Disease	Immunologic Deficiency Syndromes	MYSM1 C4A C8B	3.79e-04	23	183	3	C0021051
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ANKRD31 LCP1 JMJD1C PMPCA SYNE2 AHSG NLRC5 PMFBP1	4.91e-04	291	183	8	EFO_0008317, EFO_0020946
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	5.65e-04	6	183	2	cv:C0410189
Disease	Congenital muscular dystrophy (disorder)	ITGA7 SYNE2	5.65e-04	6	183	2	C0699743
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	5.65e-04	6	183	2	C0410189
Disease	CD97 antigen measurement	C6 C7	5.65e-04	6	183	2	EFO_0020250
Disease	carbonic anhydrase 4 measurement	C6 C7	5.65e-04	6	183	2	EFO_0020230
Disease	mental or behavioural disorder, substance abuse	MGMT LUZP2	5.65e-04	6	183	2	EFO_0000677, MONDO_0002491
Disease	hydrocephalus (is_implicated_in)	MPDZ CCDC88C	5.65e-04	6	183	2	DOID:10908 (is_implicated_in)
Disease	kallikrein‐6 measurement	KLK6 C7	5.65e-04	6	183	2	EFO_0010622
Disease	calcineurin subunit B type 1 measurement	C6 C7	7.87e-04	7	183	2	EFO_0020215
Disease	Alzheimer's disease 1 (implicated_via_orthology)	KLC2 KLC1	7.87e-04	7	183	2	DOID:0080348 (implicated_via_orthology)
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	7.87e-04	7	183	2	C0751337
Disease	renal cell carcinoma (is_implicated_in)	AKT3 MET C4A C4B	9.04e-04	69	183	4	DOID:4450 (is_implicated_in)
Disease	cholesteryl esters to total lipids in large LDL percentage	LCP1 JMJD1C NLRC5	9.28e-04	31	183	3	EFO_0022249
Disease	apolipoprotein B measurement	ANKRD31 DPYSL5 PUM2 RRBP1 LCP1 PMPCA SYNE2 PPP1R37 CNPY3 RP1 C8B PMFBP1	9.37e-04	663	183	12	EFO_0004615
Disease	Alzheimer disease	ANKRD31 MRC1 HECW1 RFC3 MGMT PPP1R37 DIO2 PLEKHA1 LUZP2 KLHL4	9.48e-04	485	183	10	MONDO_0004975
Disease	testis-expressed sequence 29 protein measurement	C7 C8B	1.05e-03	8	183	2	EFO_0802125
Disease	intellectual disability (implicated_via_orthology)	CUL4B MEF2A PREB ATF7IP2	1.23e-03	75	183	4	DOID:1059 (implicated_via_orthology)
Disease	Liver carcinoma	CENPE ACO2 HTATIP2 ARHGAP11A CDCA2 MET EXO1 TACC3 VCAM1 RAD54L	1.32e-03	507	183	10	C2239176
Disease	apolipoprotein D measurement	C6 C7	1.34e-03	9	183	2	EFO_0020156
Disease	complement component C8 measurement	C7 C8B	1.34e-03	9	183	2	EFO_0008094
Disease	kallikrein-14 measurement	C6 C7	1.34e-03	9	183	2	EFO_0020513
Disease	visceral heterotaxy (implicated_via_orthology)	ODAD2 DAW1 OSBPL1A	1.56e-03	37	183	3	DOID:0050545 (implicated_via_orthology)
Disease	tropomyosin beta chain measurement	C6 C7	1.67e-03	10	183	2	EFO_0020787
Disease	triglycerides to total lipids in large VLDL percentage	ANKRD31 LCP1 NLRC5	1.82e-03	39	183	3	EFO_0022332
Disease	Intellectual Disability	INPP4A ATP8A2 SYNE1 NSD1 PREPL PRR12 TAF1 TFB2M PUM1	1.99e-03	447	183	9	C3714756
Disease	Nephrosclerosis	ALPK1 ALOX5	2.03e-03	11	183	2	C0027719
Disease	tumor necrosis factor receptor superfamily member 11B measurement	C6 C7	2.03e-03	11	183	2	EFO_0020801
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ANKRD31 LCP1 PMPCA AHSG	2.05e-03	86	183	4	EFO_0008595, EFO_0020945
Disease	complement component C7 measurement	C6 C7	2.42e-03	12	183	2	EFO_0008093
Disease	tyrosine-protein kinase ZAP-70 measurement	C6 C7	2.42e-03	12	183	2	EFO_0020833
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 LCP1 JMJD1C PMPCA SYNE2 NLRC5	2.70e-03	222	183	6	EFO_0008317, EFO_0020943
Disease	complement component C6 measurement	C6 C7	2.85e-03	13	183	2	EFO_0020281
Disease	Kartagener syndrome (implicated_via_orthology)	ODAD2 DAW1	3.31e-03	14	183	2	DOID:0050144 (implicated_via_orthology)
Disease	pancreatic cancer (is_marker_for)	MET MGMT ALOX5 VCAM1	3.66e-03	101	183	4	DOID:1793 (is_marker_for)
Disease	ovarian carcinoma (is_implicated_in)	CCNG1 AKT2	3.81e-03	15	183	2	DOID:4001 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ANKRD31 LCP1 JMJD1C PMPCA AHSG NLRC5	3.88e-03	239	183	6	EFO_0008317, EFO_0020945
Disease	free cholesterol in large LDL measurement	ANKRD31 LCP1 JMJD1C	3.93e-03	51	183	3	EFO_0022176
Disease	forced expiratory volume	CERKL SYNE1 TRIM39 MEF2A JMJD1C DST ANKDD1A PLXNA4 DIO2 MICAL3 TOP2B PMFBP1	3.93e-03	789	183	12	EFO_0004314
Disease	sleep duration, triglyceride measurement	ZNF273 LCP1 JMJD1C MICAL3	4.06e-03	104	183	4	EFO_0004530, EFO_0005271
Disease	type 2 diabetes mellitus (implicated_via_orthology)	AKT3 ZMPSTE24 RPS6KB2 AKT2	4.21e-03	105	183	4	DOID:9352 (implicated_via_orthology)
Disease	FEV/FEC ratio	LRRC32 NSD1 CNKSR2 RRBP1 RFC3 CRABP1 JMJD1C HOXA7 PRR12 MET DST SYNE2 ANKDD1A MICAL3 TOP2B KPNA2	4.24e-03	1228	183	16	EFO_0004713
Disease	Urticaria	ALOX5 VCAM1	4.34e-03	16	183	2	C0042109
Disease	Dermatitis	NOD2 VCAM1	4.34e-03	16	183	2	C0011603
Disease	gliosarcoma	MGMT TACC3	4.34e-03	16	183	2	C0206726
Disease	triglycerides to total lipids in very large VLDL percentage	ANKRD31 LCP1 JMJD1C	4.38e-03	53	183	3	EFO_0022340
Disease	alkaline phosphatase measurement	TRAF7 RRBP1 LCP1 JMJD1C DALRD3 GSN MGMT PMPCA BCAP29 PPP1R37 MICAL3 RP1 STK38L PMFBP1	4.51e-03	1015	183	14	EFO_0004533
Disease	Alzheimer disease, educational attainment	FNIP2 JMJD1C SKOR2 PPP1R37 LUZP2 TACC3	4.55e-03	247	183	6	EFO_0011015, MONDO_0004975
Disease	SLAM family member 7 measurement	DDR2 C7	4.89e-03	17	183	2	EFO_0008287
Disease	proprotein convertase subtilisin/kexin type 7 measurement	DSCAML1 CEP164	4.89e-03	17	183	2	EFO_0008270
Disease	Antibody Deficiency Syndrome	C4A C8B	4.89e-03	17	183	2	C0003257
Disease	respiratory symptom change measurement, response to placebo	CDCA2 ATF7IP2	4.89e-03	17	183	2	EFO_0008344, EFO_0010068
Disease	cholesteryl esters to total lipids in large VLDL percentage	ANKRD31 LCP1 JMJD1C	5.11e-03	56	183	3	EFO_0022250
Disease	Glioblastoma Multiforme	AKT3 MET MGMT TAF1L	5.12e-03	111	183	4	C1621958
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 LCP1 JMJD1C	5.37e-03	57	183	3	EFO_0022284
Disease	Bone marrow hypocellularity	BRIP1 MYSM1	5.48e-03	18	183	2	C1855710
Disease	triglycerides to total lipids in small VLDL percentage	ANKRD31 LCP1 JMJD1C	5.64e-03	58	183	3	EFO_0022338
Disease	cholesterol in IDL measurement	ANKRD31 LCP1 JMJD1C	5.64e-03	58	183	3	EFO_0021899
Disease	free cholesterol to total lipids in very large VLDL percentage	ANKRD31 LCP1 JMJD1C	5.91e-03	59	183	3	EFO_0022289
Disease	Autistic Disorder	NSD1 JMJD1C MET CNTN3 C4B PRLR	5.92e-03	261	183	6	C0004352
Disease	Pancreatic carcinoma	AKT2 ALOX5	6.10e-03	19	183	2	C0235974
Disease	total lipids in IDL	ANKRD31 LCP1 JMJD1C	6.20e-03	60	183	3	EFO_0022161

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEDTSLCQFHKAGGK	USP26	661	Q9BXU7
CDHLIEAQVGGEKDL	ACO2	126	Q99798
EKLSCDLKIHGLEQE	AZI2	161	Q9H6S1
DGHIKITDFGLCKEG	AKT2	286	P31751
ELCPHKDGALKRTDN	MLLT6	66	P55198
IQESVGKKHCLLELG	CARD10	911	Q9BWT7
ACEGKLELSVDGAKQ	C4B	566	P0C0L5
HNEIGEKCSDAGLKE	CRYBG3	891	Q68DQ2
LVLDVKGGNYCDKTH	CRYBG3	2936	Q68DQ2
EKGKHCILDVSGNAI	DLG1	801	Q12959
ILKSHGKDEECVLEA	BCAP29	161	Q9UHQ4
ALTCVDGLHVEDKQK	AKAP11	1076	Q9UKA4
CKELQLEKHKGEILG	APBA2	566	Q99767
KEVHVLCLGLDNSGK	ARL6	16	Q9H0F7
CVKKLLELGASVDHG	ASB11	211	Q8WXH4
HGLEETAAKCKGLGA	HSD17B11	71	Q8NBQ5
IGKNCDKFGIVVHEL	BMP1	201	P13497
CGVNADVEKHLELGK	DNAJC3	31	Q13217
SLKNTAGCEHELLKE	CRISP2	216	P16562
GDKQETAINIGHSCK	ATP8A1	686	Q9Y2Q0
HCTDLGNLLGKENDV	ATP8A2	746	Q9NTI2
KDGHIKITDFGLCKE	AKT3	281	Q9Y243
KNLHLCEAKEAFEIG	ALPK1	321	Q96QP1
CLHRDLQGGIKDLSK	RALBP1	411	Q15311
GDIKGETCSAKQHLD	PCGF3	106	Q3KNV8
LSKKCYEAGHLENGI	NSD1	1431	Q96L73
GLVICDEGHRLKNSE	RAD54L	291	Q92698
ENKIHCTQTLLEGDG	CRABP1	91	P29762
KALKNKVDHGEGCLS	ARHGAP11B	96	Q3KRB8
ECKIKHGLSEKGDSQ	OCIAD2	136	Q56VL3
ELDGHVLKCVKDQNG	PUM2	836	Q8TB72
DKLLQKERLHGEGCE	INPP4A	546	Q96PE3
HTDAAEEVLLEKKGC	HIBCH	31	Q6NVY1
SLKKIEDCIRAGQHG	PARP2	281	Q9UGN5
DKDSGLNGEIVCKLH	PCDH18	386	Q9HCL0
TEGIECLQKHSKING	CCNG1	221	P51959
DADLVHHCIKKGGNV	ANKRD31	501	Q8N7Z5
LGVHTKGADIDALCV	PAPOLB	106	Q9NRJ5
GTQEKIAEGATCHLL	DIO2	101	Q92813
KGTLKAFQELCDHLE	MICAL3	26	Q7RTP6
AELAKAGGCKHFNLL	HTATIP2	116	Q9BUP3
REKQKEGHSLDGACI	KIAA1671	541	Q9BY89
ADKGAGVKVESELLC	GFI1	231	Q99684
LHEISCKSLEGQEGL	LRRK1	801	Q38SD2
CLAAKELDGVEEKHF	MYO19	826	Q96H55
KEKLGEGQFGEVHLC	DDR2	566	Q16832
EHLKENGGQKICILA	IBTK	396	Q9P2D0
EKCSFLETKLQGIGH	DST	5161	Q03001
GNHGLEKLSCDADLV	HECW1	1156	Q76N89
KKQLLCGAAIGTHED	IMPDH2	241	P12268
LGKLELSGCEQGLHE	MGMT	16	P16455
GAHKTDCLKLAEAGE	JMJD1C	1336	Q15652
VHAENGDLIAEGAKK	DPYS	191	Q14117
KKIELGHDGASPESC	LOXHD1	1486	Q8IVV2
ESGLKCGELEKENHQ	CCDC88C	491	Q9P219
KALETCGGDLKQAEI	TSFM	66	P43897
CHVVNIGAEDLKEGK	LCP1	206	P13796
KHGGKEHINICEVLN	PLXNA4	1076	Q9HCM2
GPLDHDDQCGKQKLA	PLXNA4	1866	Q9HCM2
QLGDLVCSDHLQEGK	L3MBTL1	796	Q9Y468
VCSDHLQEGKGILET	L3MBTL1	801	Q9Y468
KGRGKHSNCIIDLEK	NLRP1	641	Q9C000
LDSLDKKVHQLGCEA	FRYL	1141	O94915
CGEAHTLALNDKGQV	HERC4	91	Q5GLZ8
LILADGKGDLKCHIT	GANC	121	Q8TET4
KKDLLGHFGCVNAIE	DCAF5	46	Q96JK2
KCIAKLEGHEGEISK	DAW1	336	Q8N136
HLGTIQDLLEKECGV	KDM4D	156	Q6B0I6
LLENGKTCKDGATEL	LRP6	316	O75581
KGDECELLGHSKNIR	TUFM	286	P49411
VICKDKLQGIEVGHF	PRSS37	196	A4D1T9
EALNKKEHRGCDSPD	MEF2A	86	Q02078
GNVEIINHKTGDKCV	OSBPL1A	726	Q9BXW6
KEHCQQLGDIGLDLT	EXOC8	526	Q8IYI6
GEIDIVNHKTGDKCN	OSBP	596	P22059
GDAQGCTELLNVAHK	KLHL4	291	Q9C0H6
LQEKHLEQLCKALGG	NLRC5	986	Q86WI3
CKQALEDLEKTSGHD	KLC2	221	Q9H0B6
ELDGHVLKCVKDQNG	PUM1	956	Q14671
GLEHELSCSKNEKEL	PPP1R37	661	O75864
KAEDCIDTKLNGILH	BRIP1	1186	Q9BX63
ECGGLDKIEALQNHE	KPNA2	466	P52292
SHVRPEDCEKGGLKN	LRRC32	611	Q14392
SKVDGILSNCGIEKE	FBH1	271	Q8NFZ0
HEPKKVADLGCGDTS	HENMT1	46	Q5T8I9
AKEDGTLETLKNIGC	HEATR3	571	Q7Z4Q2
ACGQLKKEQGVHRLE	GRM6	56	O15303
CILDEGHVIKNGKTK	BTAF1	1401	O14981
LKNSGLTEEEAKHCV	C6	386	P13671
EHIPKGNNCLDAAKA	GFRA1	146	P56159
GKCLDGIVKAAESID	FNBP1	246	Q96RU3
KEHAVEGDCDFQLLK	AHSG	106	P02765
IKGHAKELNCTARGE	DSCAML1	801	Q8TD84
LHGTGSDEKLKQCLV	FNIP2	961	Q9P278
AQGKGQKLCEIERIH	DEK	81	P35659
NHVLKGKDTSCLAEQ	CNPY3	196	Q9BT09
HGCKELENALKAASG	C7	351	P10643
LKECELQGFDGGHRK	CERKL	216	Q49MI3
CDVGKHFNSKLGLSD	BLMH	326	Q13867
TECRNKHEGIADKLL	ATF7IP2	351	Q5U623
LSGNKLCGIHAEESK	LUZP2	141	Q86TE4
LHRKGFDCGLEAKNL	MAN2A2	1076	P49641
GSAKDLAILQCHGEL	LYPLA2	161	O95372
HCLGDVLIENTKESK	CDCA2	791	Q69YH5
KKALVEGQSHLCGEQ	DND1	196	Q8IYX4
KAHGEKGLHIDQLVC	CUL9	1881	Q8IWT3
CKASALKHGGDLAQD	DALRD3	341	Q5D0E6
LKSEDCFILDHGKDG	GSN	326	P06396
RAEIHFLKQGCGEDK	ITGA7	671	Q13683
CLHDLTNKGIGEEID	FBXL5	446	Q9UKA1
KQGCKNEEVLAVLGH	ZMPSTE24	321	O75844
EQLVAKALEHCGGVD	DHRS2	101	Q13268
DAEGSTCLHLAAKKG	EHMT1	836	Q9H9B1
NHAIKKEGELSRTCD	CENPE	1106	Q02224
SEDKKITLHCEARGN	CNTN3	41	Q9P232
HACAKNDFKIGGAIE	C8B	376	P07358
TLGHCVLKAEFKEGK	CUL4B	726	Q13620
ACEGKLELSVDGAKQ	C4A	566	P0C0L4
SVCGHGKAEDLGSKL	FOCAD	1241	Q5VW36
LIKGGKVVNDDCTHE	DPYSL5	11	Q9BPU6
LAKGACDKTDEGALH	HOXA7	96	P31268
CKQALEDLEKTSGHD	KLC1	236	Q07866
DKLGADHCEDSAILK	NUP210L	1791	Q5VU65
LSELLHNCDGQLKGE	RFC3	296	P40938
LKGGILCEEDLQKSD	RP1	721	P56715
ECKNDTLLGIKGEDL	MRC1	101	P22897
AGCHLEDTQRKLQKG	PMFBP1	496	Q8TBY8
CVYHGTLLDNDGKKI	MET	1091	P08581
KDEILLTLEKHGGIC	PMPCA	126	Q10713
KALKNKVDHGEGCLS	ARHGAP11A	96	Q6P4F7
AHLAAEVEGKCLQSG	TRIM39	241	Q9HCM9
TCGHKKLEKGIQVEL	VCAM1	386	P19320
RCEELHGKNLELGKI	TACC3	661	Q9Y6A5
LDAKGHVKLSDFGLC	STK38L	221	Q9Y2H1
NDAGGKHSLECTLIL	TOP2B	466	Q02880
KGDTLIGQCADHLQA	SYNE1	3986	Q8NF91
ISNSLLIKGHGEDCI	SYNE2	6726	Q8WXH0
QKESEEAHRCLLGKA	GIMAP6	276	Q6P9H5
GHIKLTDFGLCKESI	RPS6KB2	206	Q9UBS0
LVGSAGCSEKHLLDK	ALOX5	26	P09917
DIHDKLVLKGDFDAC	MKLN1	211	Q9UL63
VLDDECKKHLAGLGA	TAF1L	56	Q8IZX4
SVLDDECKKHLAGLG	TAF1	56	P21675
GGITKLVALLDCAHD	ODAD2	576	Q5T2S8
KLVQGAESGCHSEKE	HID1	76	Q8IV36
AESGCHSEKEKQIVL	HID1	81	Q8IV36
GVRVDHLDKKGQCAL	TANC1	991	Q9C0D5
LGKNLDGKLRVIHCD	TFB2M	136	Q9H5Q4
KHALKNGDICETSGK	SMN1	51	Q16637
LHLAKKQETAAVCGE	PRR12	1546	Q9ULL5
ACQEVLEKVKLLHGG	PI4KB	51	Q9UBF8
HKGAIACAEKLAKGE	EXO1	36	Q9UQ84
DHLDCGAGKDSLEKQ	SCRN1	231	Q12765
AGHVLVKDNGLGCKD	TENT5C	76	Q5VWP2
VNSGAKIHCESKDGL	ANKDD1A	111	Q495B1
DFLVGSGCDHNVKDK	ANKDD1A	176	Q495B1
CEKGKEQHSQAEELG	CEP164	536	Q9UPV0
SLGLEDCPGVKEKAH	ARMCX1	81	Q9P291
ENSPADRCKKIHAGD	CNKSR2	246	Q8WXI2
NHALDAGKCEDKSVE	PKP3	511	Q9Y446
IHDGKEILDCGKALS	ZNF667	221	Q5HYK9
KKCGAETQHEGLELR	PREB	126	Q9HCU5
KHGEKGIDVDAENCA	RNF149	256	Q8NC42
GNEGEIHKDRAKSCN	RND2	211	P52198
HENLQLRKGCKSADE	ZNF273	141	Q14593
LDVLHRHCKGDDNGK	USP22	271	Q9UPT9
GKCEHENLQLRKGSA	ZNF714	76	Q96N38
SKCEELSGLHGQLQE	RRBP1	931	Q9P2E9
LCSGDHILKIGDTDL	MPDZ	296	O75970
HLQDEGVCSLAEGLK	NOD2	966	Q9HC29
GLIAEEGKHCFAKED	TBC1D8B	121	Q0IIM8
GHSGEEVQLCSKAIK	RPAP2	176	Q8IXW5
CEALQKELDSLHGEK	SYCE1	81	Q8N0S2
EQSCIKTEDGLKQLH	STX16	276	O14662
KGKSEELLSALGCQD	PRLR	286	P16471
CGLEDLHLRKDGENV	ZNF682	106	O95780
LHLRKDGENVGECKD	ZNF682	111	O95780
CQKTLEGHDGIVLAL	TRAF7	431	Q6Q0C0
GLADLEACIKTLHGQ	PREPL	531	Q4J6C6
CHKKEDAGAAAEALG	SKOR2	421	Q2VWA4
DSALNKLEHCKEKGD	TOPAZ1	1281	Q8N9V7
GHENLQLRKGCKSVD	ZNF91	116	Q05481
SGLGENACVKKSHEK	UBR3	281	Q6ZT12
KLKDGIQDDHESCGS	VPS13B	91	Q7Z7G8
DECSGCGKSLLHIKL	ZNF12	166	P17014
KELLGHKNCIDEIET	TSPAN2	166	O60636
LGAIHKCLGNSEDAV	TTC39C	491	Q8N584
DNLSRHGECGKKQVS	PLEKHA1	126	Q9HB21
LEGHENAEKLNCKEI	TUT4	1016	Q5TAX3
GHENLQLRKGCKSVD	ZNF254	116	O75437
EDVIHSLGTCLKLGD	USP54	261	Q70EL1
LTKEQLAEHLGDCGL	HECTD3	121	Q5T447
AEEQNKLVHGGPCDK	KLK6	16	Q92876
IGDNGVKSLCEALKH	NLRP14	741	Q86W24
KEAKILQHFGDGLCR	MUS81	61	Q96NY9
KNCNKHDGRGIIVDA	MYSM1	321	Q5VVJ2